Eureka Biotech Call 2026

6 May – 25 Sept 2026

Register
Register
Register

VIROXIS

Start-up

www.linkedin.com/company/viroxis/NEUILLY SUR SEINE, France
6 profile visits

About

Expert in virology, Viroxis develops new oncolytic virus, transfection vectors, and CAR-T treatments.

Next-generation therapeutics and modalities

Innovative cancer treatment modalities

Agricultural and veterinary innovations

Development of new vet therapies

Representatives

Head of strategy

VIROXIS

Marketplace (1)

  • Project cooperation

    Ex vivo CAR-T treatment

    Viroxis, in collaboration with Institut Gustave Roussy, has developed and optimized a new CAR-T cells preparation process, without the standard activation which leads to exhaustion. We are looking for development partners

    • Expertise offered
    • Design - setting the project scope
    • Next-generation therapeutics and modalities
    Author

    Head of strategy at VIROXIS

    PARIS, France